Abstract
The shift from empirical to science-based process development is considered to be a key factor to increase bioprocess performance and to reduce time to market for biopharmaceutical products in the near future. In the last decade, expanding knowledge in systems biology and bioprocess technology has delivered the foundation of the scientific understanding of relationships between process input parameters and process output features. Based on this knowledge, advanced process development approaches can be applied to maximize process performance and to generate process understanding. This review focuses on tools which enable the integration of physiological knowledge into cell culture process development. As a structured approach, the availability and the proposed benefit of the application of these tools are discussed for the subsequent stages of process development. The ultimate aim is to deliver a comprehensive overview of the current role of physiological understanding during cell culture process development from clone selection to the scale-up of advanced control strategies for ensuring process robustness.
Keywords: Biopharmaceuticals, cell physiology, mammalian cell culture, Process Analytical Technology, process development, quality by design.
Current Pharmaceutical Biotechnology
Title:Advanced Development Strategies for Biopharmaceutical Cell Culture Processes
Volume: 16 Issue: 11
Author(s): Denes Zalai, Aydin Golabgir, Patrick Wechselberger, Akos Putics and Christoph Herwig
Affiliation:
Keywords: Biopharmaceuticals, cell physiology, mammalian cell culture, Process Analytical Technology, process development, quality by design.
Abstract: The shift from empirical to science-based process development is considered to be a key factor to increase bioprocess performance and to reduce time to market for biopharmaceutical products in the near future. In the last decade, expanding knowledge in systems biology and bioprocess technology has delivered the foundation of the scientific understanding of relationships between process input parameters and process output features. Based on this knowledge, advanced process development approaches can be applied to maximize process performance and to generate process understanding. This review focuses on tools which enable the integration of physiological knowledge into cell culture process development. As a structured approach, the availability and the proposed benefit of the application of these tools are discussed for the subsequent stages of process development. The ultimate aim is to deliver a comprehensive overview of the current role of physiological understanding during cell culture process development from clone selection to the scale-up of advanced control strategies for ensuring process robustness.
Export Options
About this article
Cite this article as:
Zalai Denes, Golabgir Aydin, Wechselberger Patrick, Putics Akos and Herwig Christoph, Advanced Development Strategies for Biopharmaceutical Cell Culture Processes, Current Pharmaceutical Biotechnology 2015; 16 (11) . https://dx.doi.org/10.2174/1389201016666150724100450
DOI https://dx.doi.org/10.2174/1389201016666150724100450 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Prostate Cancer, miRNAs, Metallothioneins and Resistance to Cytostatic Drugs
Current Medicinal Chemistry Nanomaterials and Stem Cell Differentiation Potential: An Overview of Biological Aspects and Biomedical Efficacy
Current Medicinal Chemistry Advances in Biomarker Research for Pancreatic Cancer
Current Pharmaceutical Design Mild Improvement in Mitochondrial Function After a 3-Year Antiretroviral Treatment Interruption Despite Persistent Impairment of Mitochondrial DNA Content
Current HIV Research Opportunities to Improve the Prevention and Treatment of Cervical Cancer
Current Molecular Medicine Heterocyclic Scaffolds: Centrality in Anticancer Drug Development
Current Drug Targets Chemopreventive Properties of Peptide Lunasin: A Review
Protein & Peptide Letters The Role of the Transcription Factor E2F1 in Hepatocellular Carcinoma
Current Drug Delivery Anti-Apoptotic Genes in the Survival of Monocytic Cells During Infection
Current Genomics TGF-β1 Signalling, Connecting Aberrant Inflammation and Colorectal Tumorigenesis
Current Pharmaceutical Design Recent Advances in the Development of Selective Small Molecule Inhibitors for Cyclin-Dependent Kinases
Current Topics in Medicinal Chemistry Ultrasound Therapeutics– A Review
Current Medical Imaging Oxidative Stress in Tumor Angiogenesis - Therapeutic Targets
Current Pharmaceutical Design Beneficial and Adverse Effects of Molecularly Targeted Therapies for Acute Promyelocytic Leukemia in Central Nervous System
CNS & Neurological Disorders - Drug Targets Cell Cycle Arrest as a Therapeutic Target of Acute Kidney Injury
Current Protein & Peptide Science MicroRNAs in Human Diseases
Recent Patents on DNA & Gene Sequences Polyploidy: The Link Between Senescence and Cancer
Current Pharmaceutical Design Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer
Current Medicinal Chemistry PP-1α and PP-1γ Display Antagonism and Differential Roles in Tumorigenicity of Lung Cancer Cells
Current Molecular Medicine Enjoy the Silence: The Story of let-7 MicroRNA and Cancer
Current Genomics